Bottom line
CFOAX vs RSP: the short answer
CFOAX (Calvert Floating-Rate Advantage Fund) and RSP (Invesco S&P 500 Equal Weight ETF) are both mutual funds.
RSP is cheaper at 0.2% vs 2.79% — a difference of $259 a year per $10,000 invested.
Over five years, RSP returned +10.3% a year vs +4.3% for CFOAX.
CFOAX has a front-end sales load of up to 3.25%; the other does not.
Updated Nov 19, 2026
CFOAX vs RSP side by side
| CFOAX | RSP | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Morgan Stanley | Invesco |
| Category | Large Blend | Large Blend |
| Expense ratio | 2.79% | 0.2% |
| Annual cost per $10k | $279 | $20 |
| 10-yr cost on $10k (prospectus) | $3,621 | $255 |
| Max front load | 3.25% | None |
| 12b-1 fee | 0.25% | — |
| 1-yr return | +0.0% | +11.3% |
| 5-yr return (annualized) | +4.3% | +10.3% |
| 10-yr return (annualized) | — | +11.5% |
| Best quarter | +7.3% | +21.6% |
| Worst quarter | −12.5% | −26.6% |
| Net assets (fund) | — | $96.5B |
| Number of holdings | — | 508 |
| Portfolio turnover | 19% | 27% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | CFOAX | RSP | Difference |
|---|---|---|---|
| 2025 | +3.4% | +11.3% | −7.9% |
| 2024 | +8.6% | +12.8% | −4.2% |
| 2023 | +13.5% | +13.7% | −0.3% |
| 2022 | −3.5% | −11.7% | +8.1% |
| 2021 | +4.1% | +29.3% | −25.3% |
| 2020 | +0.4% | +12.7% | −12.3% |
| 2019 | +9.1% | +29.0% | −19.9% |
| 2018 | −1.5% | −7.8% | +6.4% |
Source: Fund prospectus bar charts
Holdings overlap
CFOAX and RSP share none of their top holdings.
CFOAX top 10
RSP top 10
- Invesco Private Prime Fund — 3.09%
- Invesco Private Government Fund — 1.15%
- PayPal Holdings, Inc. — 0.27%
- Bio-Techne Corp. — 0.27%
- Zebra Technologies Corp. — 0.26%
- Global Payments Inc. — 0.26%
- Expedia Group, Inc. — 0.26%
- DoorDash, Inc. — 0.25%
- IQVIA Holdings Inc. — 0.25%
- Baxter International Inc. — 0.25%
FAQ
What is the difference between CFOAX and RSP?
Which is cheaper, CFOAX or RSP?
Should I own both CFOAX and RSP?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.